Drugs / GHB
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04322214 | Jan → Mar 2020 | HIV infectious disease | Fight AIDS and Infectious Diseases Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GHB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04322214 ↗ |
| Route | Oral | “single oral dose of GHB (25 mg/kg) on days 5 and 17” NCT04322214 ↗ |